An Open-Label Study of the Pharmacokinetics and Safety of MNK-155 (7.5 mg in Postsurgical Adolescent Subjects (Ages 12 to 17) With Moderate to Severe Acute Pain

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2015 - September 30, 2016